Evidence map›Paper›PMID 37090250›Full record

ReviewFrontiers in chemistry2023

Spermidine as a promising anticancer agent: Recent advances and newer insights on its molecular mechanisms.

Parteek Prasher, Mousmee Sharma, Sachin Kumar Singh, Monica Gulati, Dinesh Kumar Chellappan, Rashi Rajput, Gaurav Gupta, Alibek Ydyrys, Marzhan Kulbayeva, Ahmad Faizal Abdull Razis and 3 more

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 28 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Polyamines in Ovarian Aging and Disease.International journal of molecular sciences · 2023
    Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 10 institutions in 6 countries.

Parteek PrasherDepartment of Chemistry, University of Petroleum and Energy Studies, Dehradun, India.
Mousmee SharmaDepartment of Chemistry, Uttaranchal University, Dehradun, India.
Sachin Kumar SinghSchool of Pharmaceutical Science, Lovely Professional University, Phagwara, India.
Monica GulatiSchool of Pharmaceutical Science, Lovely Professional University, Phagwara, India.
Dinesh Kumar ChellappanSchool of Pharmacy, International Medical University, Bukit Jalil, Malaysia.
Rashi RajputFaculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW, Australia.
Gaurav GuptaSchool of Pharmacy, Suresh Gyan Vihar University, Jaipur, Rajasthan, India.
Alibek YdyrysBiomedical Research Centre, Al-Farabi Kazakh National University, Almaty, Kazakhstan.
Marzhan KulbayevaDepartment of Biophysics, Biomedicine and Neuroscience, Al-Farabi Kazakh National University, Almaty, Kazakhstan.
Ahmad Faizal Abdull RazisDepartment of Food Science, Faculty of Food Science and Technology, Universiti Putra Malaysia, Selangor, Malaysia.
Babagana ModuNatural Medicines and Products Research Laboratory, Institute of Bioscience, Universiti Putra Malaysia, Selangor, Malaysia.
Javad Sharifi-RadFacultad de Medicina, Universidad del Azuay, Cuenca, Ecuador.
Kamal DuaFaculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW, Australia.
Al-Farabi Kazakh National University · KZLovely Professional University · INUniversity of Technology Sydney · AUGyan Vihar University · INInternational Medical University · MYUniversidad del Azuay · ECUniversiti Putra Malaysia · MYUniversity of Maiduguri · NGUniversity of Petroleum and Energy Studies · INUttaranchal University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Spermidine is a naturally occurring polyamine compound found in semen. It is also found in several plant sources and boasts a remarkable biological profile, particularly with regards to its anticancer properties. Spermidine specifically interferes with the tumour cell cycle, resulting in the inhibition of tumor cell proliferation and suppression of tumor growth. Moreover, it also triggers autophagy by regulating key oncologic pathways. The increased intake of polyamines, such as spermidine, can suppress oncogenesis and slow the growth of tumors due to its role in anticancer immunosurveillance and regulation of polyamine metabolism. Spermidine/spermine N-1-acetyltransferase (SSAT) plays a critical role in polyamine homeostasis and serves as a diagnostic marker in human cancers. Chemically modified derivatives of spermidine hold great potential for prognostic, diagnostic, and therapeutic applications against various malignancies. This review discusses in detail the recent findings that support the anticancer mechanisms of spermidine and its molecular physiology.

Indexed as

anticancer immunosurveillanceanticancer propertiescell proliferationdiagnostic markerpolyaminesspermidine

Identifiers

PMID37090250
PMCPMC10117651
OpenAlexW4362672821

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.